Trials / Completed
CompletedNCT00833911
An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 392 (actual)
- Sponsor
- Labopharm Inc. · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect information regarding the long-term (6 and 12 months) safety of Tramadol HCl Once-A-Day(OAD) 300 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol Once A Day |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2009-02-02
- Last updated
- 2012-04-30
- Results posted
- 2009-06-02
Source: ClinicalTrials.gov record NCT00833911. Inclusion in this directory is not an endorsement.